19 May 2013
Keywords: indian, patent, case, driving, china, swiss, drug
Article | 10 September 2007
Swiss drug major Novartis has warned of a shift in the industry's R&D priorities away from India towards China, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 September 2007
17 May 2013
© 2013 thepharmaletter.com